SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,146,000 | -39.0% | 9,970 | -17.1% | 0.14% | +20.4% |
| Q3 2014 | $1,878,000 | -44.8% | 12,020 | -56.4% | 0.11% | -25.2% |
| Q2 2014 | $3,401,000 | -18.9% | 27,570 | -31.9% | 0.15% | +36.0% |
| Q1 2014 | $4,194,000 | -53.8% | 40,480 | -59.9% | 0.11% | -31.5% |
| Q4 2013 | $9,077,000 | -0.3% | 100,914 | -25.8% | 0.16% | +8.0% |
| Q3 2013 | $9,102,000 | -32.6% | 136,090 | -33.3% | 0.15% | -17.6% |
| Q2 2013 | $13,503,000 | – | 204,120 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |